Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Haupt

Showing results (51-60 of 105) with videos related to

Pageof 11
Sort By:
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|January 1, 1973
[Longtime effect of blood sugar decreasing sulfonamides on glucose tolerance and insulin secretion in adult diabetic patients]E Haupt, U Cordes, R Petzoldt, et al.
Arzneimittel-Forschung|December 1, 1972
[Studies on the mechanism of action of sulfonylurea compounds. Effect of glibornuride and insulin on blood sugar, plasma catecholamines and on the immunologically determinable insulin following blockade of adrenergic receptors]U Cordes, J Beyer, G Sell, et al.
Journal of Fluorescence|June 5, 2008
Synthesis and spectral properties of novel fluorescent poly(oxyethylene phosphate) tris(beta-diketonate) europium (III) complexesS Stanimirov, A Vasilev, E Haupt, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|January 1, 1971
[Changes of blood sugar, serum insulin and free fatty acids following tolbutamide and glibenclamide in subjects of normal metabolism, pretreated with alpha and beta receptor blockaders]E Haupt, U Cordes, W Köberich, et al.
Die Medizinische Welt|January 11, 1974
[Effect of a combined antibacterial therapy using sulfamethoxazole and trimethoprim on the metabolism of diabetics]U Schwedes, E Haupt, K M Bartelt, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|January 1, 1972
[Betacytotropic and antilipolytic effect of critical doses of tolbutamide and glibenclamide]C Rosak, E Haupt, K M Bartelt, et al.
La Clinica Terapeutica|September 15, 1991
[Factor VIII inhibitors in non-hemophiliac patients. A report of cases and therapeutic prospects]E Haupt, M L Rolandelli, G Bardellini, et al.
Arzneimittel-Forschung|December 1, 1972
[Extrapancreatic effects of sulfonylurea compounds. V. Studies on the antilipolytic effect of glibornuride]C Rosak, K M Bartelt, E Haupt, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|December 14, 1999
The KID Study VI: diabetic complications and associated diseases in younger type 2 diabetics still performing a profession. Prevalence and correlation with duration of diabetic state, BMI and C-peptideE Haupt, A Benecke, A Haupt, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|January 1, 1972
[Insulin secretion after oral and intravenous administration of various 1st and 2d generation sulfonylurea derivatives in equipotential dosage]E Haupt, W Köberich, C Rosak, et al.
Pageof 11

Showing results (51-60 of 105) with videos related to

Sort By:
Pageof 11
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|January 1, 1973
[Longtime effect of blood sugar decreasing sulfonamides on glucose tolerance and insulin secretion in adult diabetic patients]E Haupt, U Cordes, R Petzoldt, et al.
Arzneimittel-Forschung|December 1, 1972
[Studies on the mechanism of action of sulfonylurea compounds. Effect of glibornuride and insulin on blood sugar, plasma catecholamines and on the immunologically determinable insulin following blockade of adrenergic receptors]U Cordes, J Beyer, G Sell, et al.
Journal of Fluorescence|June 5, 2008
Synthesis and spectral properties of novel fluorescent poly(oxyethylene phosphate) tris(beta-diketonate) europium (III) complexesS Stanimirov, A Vasilev, E Haupt, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|January 1, 1971
[Changes of blood sugar, serum insulin and free fatty acids following tolbutamide and glibenclamide in subjects of normal metabolism, pretreated with alpha and beta receptor blockaders]E Haupt, U Cordes, W Köberich, et al.
Die Medizinische Welt|January 11, 1974
[Effect of a combined antibacterial therapy using sulfamethoxazole and trimethoprim on the metabolism of diabetics]U Schwedes, E Haupt, K M Bartelt, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|January 1, 1972
[Betacytotropic and antilipolytic effect of critical doses of tolbutamide and glibenclamide]C Rosak, E Haupt, K M Bartelt, et al.
La Clinica Terapeutica|September 15, 1991
[Factor VIII inhibitors in non-hemophiliac patients. A report of cases and therapeutic prospects]E Haupt, M L Rolandelli, G Bardellini, et al.
Arzneimittel-Forschung|December 1, 1972
[Extrapancreatic effects of sulfonylurea compounds. V. Studies on the antilipolytic effect of glibornuride]C Rosak, K M Bartelt, E Haupt, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|December 14, 1999
The KID Study VI: diabetic complications and associated diseases in younger type 2 diabetics still performing a profession. Prevalence and correlation with duration of diabetic state, BMI and C-peptideE Haupt, A Benecke, A Haupt, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|January 1, 1972
[Insulin secretion after oral and intravenous administration of various 1st and 2d generation sulfonylurea derivatives in equipotential dosage]E Haupt, W Köberich, C Rosak, et al.
Pageof 11